Initiating and delivering clinical research (PII/PID)

The Department of Health wishes to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivery clinical research. The aim is to increase the number of patients who have the opportunity to participate in research and to enhance the nation’s attractiveness as a host for research.

We report on a quarterly basis to the Department of Health our performance against national benchmarks for clinical trials hosted at Chelsea and Westminster.

The first benchmark relates to the initiation of clinical research. Research departments should facilitate swift research set-up following receipt of a valid research application to the recruitment of the first participant.

The second benchmark relates to the delivery of clinical research. For all commercial clinical trials, the agreed target number of participants should be recruited within the agreed timeframe.

35th report

Our 35th report to the Department of Health relates to Q2 2022/23 and includes analysis for West Middlesex University Hospital:

34th report

Our 34th report to the Department of Health relates to Q1 2022/23 and includes analysis for West Middlesex University Hospital:

33nd report

Our 33nd report to the Department of Health relates to Q4 2021/22 and includes analysis for West Middlesex University Hospital:

32nd report

Our 32nd report to the Department of Health relates to Q3 2021/22 and includes analysis for West Middlesex University Hospital:

31st report

Our 31st report to the Department of Health relates to Q2 2021/22 and includes analysis for West Middlesex University Hospital:

30th report

Our 30th report to the Department of Health relates to Q1 2021/22 and includes analysis for West Middlesex University Hospital:

29th report

Our 29th report to the Department of Health relates to Q4 2020/21 and includes analysis for West Middlesex University Hospital:

28th report

Our 28th report to the Department of Health relates to Q3 2020/21 and includes analysis for West Middlesex University Hospital:

27th report

Our 27th report to the Department of Health relates to Q2 2020/21 and includes analysis for West Middlesex University Hospital:

26th report

Our 26th report to the Department of Health relates to Q1 2020/21 and includes analysis for West Middlesex University Hospital:

25th report

Our 25th report to the Department of Health relates to Q4 2019/20 and includes analysis for West Middlesex University Hospital:

Twenty-fourth report

Our 24th report to the Department of Health relates to Q3 2019/20 and includes analysis for West Middlesex University Hospital:

23rd report

Our 23nd report to the Department of Health relates to Q2 2019/20 and includes analysis for West Middlesex University Hospital:

22nd report

Our 22nd report to the Department of Health relates to Q1 2019/20 and includes analysis for West Middlesex University Hospital:

21st report

Our 21st report to the Department of Health relates to Q4 2018/19 and includes analysis for West Middlesex University Hospital:

20th report

Our 20th report to the Department of Health relates to Q3 2018/19 and includes analysis for West Middlesex University Hospital:

19th report

Our 19th report to the Department of Health relates to Q2 2018/19 and includes analysis for West Middlesex University Hospital:

18th report

Our 18th report to the Department of Health relates to Q1 2018/19 and includes analysis for West Middlesex University Hospital:

17th report

Our 17th report to the Department of Health relates to Q4 2017/18 and includes analysis for West Middlesex University Hospital:

16th report

Our 16th report to the Department of Health relates to Q3 2017/18 and includes analysis for West Middlesex University Hospital:

15th report

Our 15th report to the Department of Health relates to Q2 2017/18 and includes analysis for West Middlesex University Hospital:

14th report

Our 14th report to the Department of Health relates to Q1 2017/18 and includes analysis for West Middlesex University Hospital:

13th report

Our 13th report to the Department of Health relates to Q4 2016/17 and includes analysis for West Middlesex University Hospital:

12th report

Our 12th report to the Department of Health relates to Q3 2016/17 and includes analysis for West Middlesex University Hospital:

11th report

Our 11th report to the Department of Health relates to Q2 2016/17 and includes analysis for West Middlesex University Hospital:

10th report

Our 10th report to the Department of Health relates to the period 01 Jul 2015 to 30 Jun 2016 and includes analysis for West Middlesex University Hospital:

9th report

Our 9th report to the Department of Health relates to the period 01 Apr 2015 to 31 Mar 2016 and includes analysis for the former West Middlesex University Hospital NHS Trust:

8th report

Our 8th report to the Department of Health relates to the period 01 Jan 2015 to 31 Dec 2015 and includes analysis for the former West Middlesex University Hospital NHS Trust:

7th report

Our 7th report to the Department of Health relates to the period 01 Oct 2014 to 30 Sep 2015 and includes analysis for the former West Middlesex University Hospital NHS Trust:

6th report

Our 6th report to the Department of Health relates to the period 01 Jul 2014 to 30 Jun 2015:

Brief analysis:

  • Our adjusted achievement performance for the initiation target (which removes from the analysis all trials whereby the target could still be met (ie, 70 calendar days are yet to pass), or where the reason for failing to meet the target is not the fault of the NHS organisation, but is the fault of the sponsor) was 100%. We have recently acquired the former West Middlesex University Hospital NHS Trust, whom reported for the first time during this quarter and have a performance achievement of 100% also.
  • Our achievement performance for the delivery target was 42.9%, against a group average of 45.2% (we are compared nationally with Trusts hosting a similar number of commercial clinical trials). We have recently acquired the former West Middlesex University Hospital NHS Trust, whom reported for the first time during this quarter and have a performance achievement of 50%, against a group average of 40.7%.

5th report

Our 5th report to the Department of Health relates to the period 01 Apr 2014 to 31 Mar 2015:

Brief analysis:

  • Our adjusted achievement performance for the initiation target (which removes from the analysis all trials whereby the target could still be met (ie, 70 calendar days are yet to pass), or where the reason for failing to meet the target is not the fault of the NHS organisation, but is the fault of the sponsor) was 100%.
  • Our achievement performance for the delivery target was 43.3%, against a group average of 50.1% (we are compared nationally with Trusts hosting a similar number of commercial clinical trials).

4th report

Our 4th report to the Department of Health relates to the period 01 Jan 2014 to 30 Dec 2014:

Brief analysis:

  • Our adjusted achievement performance for the initiation target (which removes from the analysis all trials whereby the target could still be met (ie, 70 calendar days are yet to pass), or where the reason for failing to meet the target is not the fault of the NHS organisation, but is the fault of the sponsor) was 93.8%.
  • Our achievement performance for the delivery target was 46.9%, against a group average of 42.5% (we are compared nationally with Trusts hosting a similar number of commercial clinical trials).

3rd report

Our 3rd report to the Department of Health relates to the period 01 Oct 2013 to 30 Sep 2014:

Brief analysis:

  • Our adjusted achievement performance for the initiation target (which removes from the analysis all trials whereby the target could still be met (ie, 70 calendar days are yet to pass), or where the reason for failing to meet the target is not the fault of the NHS organisation, but is the fault of the sponsor) was 87.5%.
  • Our achievement performance for the delivery target was 46.4%, against a group average of 47.0% (we are compared nationally with Trusts hosting a similar number of commercial clinical trials).

2nd report

Our 2nd report to the Department of Health relates to the period 01 Jul 2013 to 30 Jun 2014:

Brief analysis:

  • Our adjusted achievement performance for the initiation target (which removes from the analysis all trials whereby the target could still be met (ie, 70 calendar days are yet to pass), or where the reason for failing to meet the target is not the fault of the NHS organisation, but is the fault of the sponsor) was 56.5%.
  • Our achievement performance for the delivery target was 53.1%, against a group average of 43.7% (we are compared nationally with Trusts hosting a similar number of commercial clinical trials).

1st report

Our 1st report to the Department of Health relates to the period 01 Apr 2013 to 31 Mar 2014:

Brief analysis:

  • Our adjusted achievement performance for the initiation target (which removes from the analysis all trials whereby the target could still be met (ie, 70 calendar days are yet to pass), or where the reason for failing to meet the target is not the fault of the NHS organisation, but is the fault of the sponsor) was 34.6%.
  • Our achievement performance for the delivery target was 47.5%, against a group average of 40.7% (we are compared nationally with Trusts hosting a similar number of commercial clinical trials).
Contributors
ruby George Vasilopoulos